Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions.

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

The highest dose of an experimental pill developed by Eli Lilly dramatically lowered an inherited form of high cholesterol in ...

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

Lilly’s drug is the only oral treatment in a field of several injectable therapies being tested to treat high Lp(a), a risk ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

They are also naturally high in cholesterol but not as high as other animal-based ... Zeman M, Vecka M, Perlík F, et al. Niacin in the treatment of hyperlipidemias in light of new clinical trials: has ...

When you've got hyperlipidemia—that's the fancy term for high cholesterol—those extra lipids begin clogging up your arteries. The Cleveland Clinic has broken it down: think of these lipids ...

Lifestyle factors such as poor diet, obesity, smoking, and excessive alcohol intake are known to contribute to high cholesterol levels. Dubbed the 'silent killer', high cholesterol often goes ...

the risks of heart disease are calculated. As a rule of thumb, less than 5.2 is low, 5.2-6.5 is average, 6.5-7.8 is moderately high and greater than 7.8 ...

The best flea and tick treatments for dogs protect your pet from these common pests, as well as lice, mites, intestinal worms, and life-threatening heartworm infections. You can find safe and ...